| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | type I interferon receptor binding | 6.74e-08 | 17 | 273 | 6 | GO:0005132 | |
| GeneOntologyMolecularFunction | calcium ion binding | DCHS2 TBC1D9B DGKB DGKG KCNIP3 TBC1D8B RYR2 CEMIP2 FAT1 FAT2 HMCN2 GCA PLA2G4F CAPS2 PCDH10 BAIAP3 DSPP CASR ADAMTS13 CLSTN1 CD93 PPP3CA PRF1 ITSN2 PCDHGB4 LRP1 MACF1 PCDH1 | 1.55e-06 | 749 | 273 | 28 | GO:0005509 |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation of STAT protein | 1.70e-08 | 24 | 269 | 7 | GO:0033139 | |
| GeneOntologyBiologicalProcess | serine phosphorylation of STAT protein | 5.56e-08 | 28 | 269 | 7 | GO:0042501 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation of STAT protein | 2.14e-07 | 21 | 269 | 6 | GO:0033141 | |
| GeneOntologyBiologicalProcess | natural killer cell activation involved in immune response | 1.08e-06 | 42 | 269 | 7 | GO:0002323 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation | GGNBP2 TXN GPD1L NTRK2 IFNA2 IFNA4 IFNA7 IFNA10 IFNA16 IFNA21 | 1.29e-05 | 137 | 269 | 10 | GO:0033135 |
| GeneOntologyBiologicalProcess | type I interferon-mediated signaling pathway | 1.52e-05 | 85 | 269 | 8 | GO:0060337 | |
| GeneOntologyBiologicalProcess | cellular response to type I interferon | 1.66e-05 | 86 | 269 | 8 | GO:0071357 | |
| GeneOntologyBiologicalProcess | response to type I interferon | 2.73e-05 | 92 | 269 | 8 | GO:0034340 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 CADM4 FAT1 FAT2 HMCN2 PCDH10 SDK1 CLSTN1 PCDHGB4 ROBO2 PCDH1 | 3.63e-05 | 187 | 269 | 11 | GO:0007156 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | TBC1D9B SETX ILK HDAC4 KIF26A MCIDAS TRPC6 RRN3P2 DGKG PLEKHM1 BMPR2 FIG4 KALRN SYNE1 NTRK2 CARMIL1 ROR2 OBSL1 NLGN1 PPP3CA MYLIP LRP1 MACF1 ROBO2 RP1 CTNNA2 | 4.88e-05 | 846 | 269 | 26 | GO:0120035 |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation | 5.35e-05 | 101 | 269 | 8 | GO:0033138 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | TBC1D9B SETX ILK HDAC4 KIF26A MCIDAS TRPC6 RRN3P2 DGKG PLEKHM1 BMPR2 FIG4 KALRN SYNE1 NTRK2 CARMIL1 ROR2 OBSL1 NLGN1 PPP3CA MYLIP LRP1 MACF1 ROBO2 RP1 CTNNA2 | 6.77e-05 | 863 | 269 | 26 | GO:0031344 |
| GeneOntologyBiologicalProcess | response to exogenous dsRNA | 7.90e-05 | 55 | 269 | 6 | GO:0043330 | |
| GeneOntologyBiologicalProcess | interferon-mediated signaling pathway | 1.11e-04 | 112 | 269 | 8 | GO:0140888 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | SETX ILK KIF26A TRPC6 RRN3P2 DGKG BMPR2 FIG4 KALRN SYNE1 NTRK2 ROR2 OBSL1 NLGN1 PPP3CA MYLIP LRP1 MACF1 ROBO2 CTNNA2 | 1.67e-04 | 612 | 269 | 20 | GO:0010975 |
| GeneOntologyBiologicalProcess | response to dsRNA | 1.70e-04 | 63 | 269 | 6 | GO:0043331 | |
| GeneOntologyBiologicalProcess | regulation of defense response to virus by host | 1.70e-04 | 63 | 269 | 6 | GO:0050691 | |
| GeneOntologyBiologicalProcess | natural killer cell activation | 2.25e-04 | 124 | 269 | 8 | GO:0030101 | |
| Domain | IGc2 | CADM4 SPEG OBSCN NCAM1 MALT1 PXDN HMCN2 SDK1 ADAMTSL1 KALRN NTRK2 ROR2 OBSL1 LINGO2 ICAM5 ROBO2 IGSF1 MYBPC2 | 1.06e-08 | 235 | 271 | 18 | SM00408 |
| Domain | Ig_sub2 | CADM4 SPEG OBSCN NCAM1 MALT1 PXDN HMCN2 SDK1 ADAMTSL1 KALRN NTRK2 ROR2 OBSL1 LINGO2 ICAM5 ROBO2 IGSF1 MYBPC2 | 1.06e-08 | 235 | 271 | 18 | IPR003598 |
| Domain | Ig_I-set | CADM4 SPEG OBSCN NCAM1 PXDN HMCN2 SDK1 ADAMTSL1 KALRN NTRK2 ROR2 OBSL1 LINGO2 ICAM5 ROBO2 MYBPC2 | 1.87e-08 | 190 | 271 | 16 | IPR013098 |
| Domain | I-set | CADM4 SPEG OBSCN NCAM1 PXDN HMCN2 SDK1 ADAMTSL1 KALRN NTRK2 ROR2 OBSL1 LINGO2 ICAM5 ROBO2 MYBPC2 | 1.87e-08 | 190 | 271 | 16 | PF07679 |
| Domain | Interferon | 9.56e-08 | 17 | 271 | 6 | PF00143 | |
| Domain | INTERFERON_A_B_D | 9.56e-08 | 17 | 271 | 6 | PS00252 | |
| Domain | Interferon_alpha/beta/delta | 9.56e-08 | 17 | 271 | 6 | IPR000471 | |
| Domain | IFabd | 9.56e-08 | 17 | 271 | 6 | SM00076 | |
| Domain | Spectrin | 1.68e-05 | 23 | 271 | 5 | PF00435 | |
| Domain | IG | CADM4 SPEG OBSCN NCAM1 MALT1 PXDN HMCN2 SDK1 ADAMTSL1 KALRN NTRK2 ROR2 OBSL1 LINGO2 ICAM5 ROBO2 IGSF1 MYBPC2 | 4.65e-05 | 421 | 271 | 18 | SM00409 |
| Domain | Ig_sub | CADM4 SPEG OBSCN NCAM1 MALT1 PXDN HMCN2 SDK1 ADAMTSL1 KALRN NTRK2 ROR2 OBSL1 LINGO2 ICAM5 ROBO2 IGSF1 MYBPC2 | 4.65e-05 | 421 | 271 | 18 | IPR003599 |
| Domain | Spectrin_repeat | 5.53e-05 | 29 | 271 | 5 | IPR002017 | |
| Domain | - | 8.21e-05 | 50 | 271 | 6 | 1.20.1250.10 | |
| Domain | SPEC | 9.06e-05 | 32 | 271 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 9.06e-05 | 32 | 271 | 5 | IPR018159 | |
| Domain | 4_helix_cytokine_core | 9.20e-05 | 51 | 271 | 6 | IPR012351 | |
| Domain | PRAME_family | 1.42e-04 | 19 | 271 | 4 | IPR026271 | |
| Domain | Aha1_N | 2.10e-04 | 2 | 271 | 2 | SM01000 | |
| Domain | Aha1_N | 2.10e-04 | 2 | 271 | 2 | PF09229 | |
| Domain | AHSA1_N | 2.10e-04 | 2 | 271 | 2 | IPR015310 | |
| Domain | EPHD | 2.58e-04 | 22 | 271 | 4 | PS51805 | |
| Domain | - | ANKRD31 ILK TRPC6 ANKRD28 BANK1 TRPC7 MIB2 ANKRD50 KANK2 ANKRD30A MPHOSPH8 ANKS3 | 2.85e-04 | 248 | 271 | 12 | 1.25.40.20 |
| Domain | IG_LIKE | CADM4 SPEG OBSCN NCAM1 MALT1 PXDN HMCN2 SDK1 ADAMTSL1 KALRN NTRK2 ROR2 OBSL1 LINGO2 ICAM5 ROBO2 IGSF1 MYBPC2 | 3.16e-04 | 491 | 271 | 18 | PS50835 |
| Domain | Ank_2 | ANKRD31 ILK TRPC6 ANKRD28 TRPC7 MIB2 ANKRD50 KANK2 ANKRD30A MPHOSPH8 ANKS3 | 3.17e-04 | 215 | 271 | 11 | PF12796 |
| Domain | ANK_REPEAT | ANKRD31 ILK TRPC6 ANKRD28 BANK1 TRPC7 MIB2 ANKRD50 KANK2 ANKRD30A MPHOSPH8 ANKS3 | 3.42e-04 | 253 | 271 | 12 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | ANKRD31 ILK TRPC6 ANKRD28 BANK1 TRPC7 MIB2 ANKRD50 KANK2 ANKRD30A MPHOSPH8 ANKS3 | 3.54e-04 | 254 | 271 | 12 | IPR020683 |
| Domain | ANK_REP_REGION | ANKRD31 ILK TRPC6 ANKRD28 BANK1 TRPC7 MIB2 ANKRD50 KANK2 ANKRD30A MPHOSPH8 ANKS3 | 3.54e-04 | 254 | 271 | 12 | PS50297 |
| Domain | Ig-like_dom | CADM4 SPEG OBSCN NCAM1 MALT1 PXDN HMCN2 SDK1 ADAMTSL1 KALRN NTRK2 ROR2 OBSL1 LINGO2 ICAM5 ROBO2 IGSF1 MYBPC2 | 4.21e-04 | 503 | 271 | 18 | IPR007110 |
| Domain | RhoGEF | 4.55e-04 | 68 | 271 | 6 | SM00325 | |
| Domain | Ankyrin_rpt | ANKRD31 ILK TRPC6 ANKRD28 BANK1 TRPC7 MIB2 ANKRD50 KANK2 ANKRD30A MPHOSPH8 ANKS3 | 4.68e-04 | 262 | 271 | 12 | IPR002110 |
| Domain | Ank | ANKRD31 ILK TRPC6 ANKRD28 TRPC7 MIB2 ANKRD50 KANK2 ANKRD30A MPHOSPH8 ANKS3 | 5.20e-04 | 228 | 271 | 11 | PF00023 |
| Domain | RhoGEF | 5.32e-04 | 70 | 271 | 6 | PF00621 | |
| Domain | DH_2 | 5.32e-04 | 70 | 271 | 6 | PS50010 | |
| Domain | - | 5.74e-04 | 71 | 271 | 6 | 1.20.900.10 | |
| Domain | DH-domain | 5.74e-04 | 71 | 271 | 6 | IPR000219 | |
| Domain | fn3 | 6.12e-04 | 162 | 271 | 9 | PF00041 | |
| Domain | - | 6.23e-04 | 3 | 271 | 2 | 1.10.238.110 | |
| Domain | DAG_kinase_N | 6.23e-04 | 3 | 271 | 2 | PF14513 | |
| Domain | DAG_kinase_typeI_N | 6.23e-04 | 3 | 271 | 2 | IPR029477 | |
| Domain | CH | 6.66e-04 | 73 | 271 | 6 | PS50021 | |
| Domain | 4_helix_cytokine-like_core | 7.16e-04 | 74 | 271 | 6 | IPR009079 | |
| Domain | CH-domain | 7.69e-04 | 75 | 271 | 6 | IPR001715 | |
| Domain | - | PRAMEF5 NAIP PXDN PRAMEF6 NLRP13 NTRK2 CARMIL1 PRAMEF20 PRAMEF12 LINGO2 FBXL16 LRRC1 SCRIB | 8.71e-04 | 321 | 271 | 13 | 3.80.10.10 |
| Domain | L_dom-like | PRAMEF5 NAIP PXDN PRAMEF6 NLRP13 NTRK2 CARMIL1 PRAMEF20 PRAMEF12 LINGO2 FBXL16 LRRC1 SCRIB | 1.06e-03 | 328 | 271 | 13 | IPR032675 |
| Domain | ANK | ANKRD31 ILK TRPC6 ANKRD28 TRPC7 MIB2 ANKRD50 KANK2 ANKRD30A MPHOSPH8 ANKS3 | 1.14e-03 | 251 | 271 | 11 | SM00248 |
| Domain | Pecanex_C | 1.23e-03 | 4 | 271 | 2 | PF05041 | |
| Domain | Neural_cell_adh | 1.23e-03 | 4 | 271 | 2 | IPR009138 | |
| Domain | CEBP_ZZ | 1.23e-03 | 4 | 271 | 2 | PF16366 | |
| Domain | RRM_7 | 1.23e-03 | 4 | 271 | 2 | PF16367 | |
| Domain | CEBP_ZZ | 1.23e-03 | 4 | 271 | 2 | IPR032296 | |
| Domain | Pecanex | 1.23e-03 | 4 | 271 | 2 | IPR007735 | |
| Domain | SH3 | ARHGAP42 MYO7A NOXA1 OBSCN MCF2L KALRN ITSN2 MACF1 ARHGEF4 SPATA13 | 1.26e-03 | 216 | 271 | 10 | PS50002 |
| Domain | CADHERIN_1 | 1.31e-03 | 113 | 271 | 7 | PS00232 | |
| Domain | Cadherin | 1.31e-03 | 113 | 271 | 7 | PF00028 | |
| Domain | - | 1.38e-03 | 114 | 271 | 7 | 2.60.40.60 | |
| Domain | CADHERIN_2 | 1.38e-03 | 114 | 271 | 7 | PS50268 | |
| Domain | CA | 1.45e-03 | 115 | 271 | 7 | SM00112 | |
| Domain | SH3_domain | ARHGAP42 MYO7A NOXA1 OBSCN MCF2L KALRN ITSN2 MACF1 ARHGEF4 SPATA13 | 1.45e-03 | 220 | 271 | 10 | IPR001452 |
| Domain | Cadherin-like | 1.52e-03 | 116 | 271 | 7 | IPR015919 | |
| Domain | FN3 | 1.56e-03 | 185 | 271 | 9 | SM00060 | |
| Domain | Cadherin | 1.68e-03 | 118 | 271 | 7 | IPR002126 | |
| Domain | EF-hand_1 | 1.72e-03 | 152 | 271 | 8 | PF00036 | |
| Domain | Pyr_OxRdtase_I_AS | 2.04e-03 | 5 | 271 | 2 | IPR012999 | |
| Domain | Pyr_redox_dim | 2.04e-03 | 5 | 271 | 2 | PF02852 | |
| Domain | SAPAP | 2.04e-03 | 5 | 271 | 2 | IPR005026 | |
| Domain | GKAP | 2.04e-03 | 5 | 271 | 2 | PF03359 | |
| Domain | PYRIDINE_REDOX_1 | 2.04e-03 | 5 | 271 | 2 | PS00076 | |
| Domain | EF_HAND_2 | 2.08e-03 | 231 | 271 | 10 | PS50222 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_TAT_TO_TLR2_4_NFKB_SIGNALING_PATHWAY | 7.98e-08 | 17 | 199 | 6 | M47564 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CGAS_STING_SIGNALING_PATHWAY | 1.18e-07 | 18 | 199 | 6 | M47539 | |
| Pathway | BIOCARTA_IFNA_PATHWAY | 1.71e-07 | 19 | 199 | 6 | MM1571 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY | 1.71e-07 | 19 | 199 | 6 | M47450 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_9_IRF7_SIGNALING_PATHWAY | 2.41e-07 | 20 | 199 | 6 | M47617 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_II_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 3.34e-07 | 21 | 199 | 6 | M47909 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_8_9_IRF5_SIGNALING_PATHWAY | 4.54e-07 | 22 | 199 | 6 | M47897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_NFKB_SIGNALING_PATHWAY | 4.54e-07 | 22 | 199 | 6 | M47616 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 6.06e-07 | 23 | 199 | 6 | MM15634 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_IFN_SIGNALING_PATHWAY | 6.06e-07 | 23 | 199 | 6 | M47452 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MDA5_IRF7_3_SIGNALING_PATHWAY | 7.99e-07 | 24 | 199 | 6 | M47782 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_IRF7_3_SIGNALING_PATHWAY | 7.99e-07 | 24 | 199 | 6 | M47576 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 7.99e-07 | 24 | 199 | 6 | M47908 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 1.34e-06 | 26 | 199 | 6 | M982 | |
| Pathway | BIOCARTA_CYTOKINE_PATHWAY | 2.13e-06 | 28 | 199 | 6 | MM1378 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 3.29e-06 | 30 | 199 | 6 | M936 | |
| Pathway | PID_CD8_TCR_DOWNSTREAM_PATHWAY | 3.47e-06 | 65 | 199 | 8 | M272 | |
| Pathway | WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY | 4.03e-06 | 31 | 199 | 6 | M39897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY | 4.03e-06 | 31 | 199 | 6 | M47964 | |
| Pathway | BIOCARTA_INFLAM_PATHWAY | 5.92e-06 | 33 | 199 | 6 | MM1379 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 7.10e-06 | 34 | 199 | 6 | MM15631 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 7.85e-06 | 52 | 199 | 7 | M13103 | |
| Pathway | WP_CYTOSOLIC_DNASENSING_PATHWAY | 8.40e-06 | 73 | 199 | 8 | M39837 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 8.47e-06 | 35 | 199 | 6 | M48246 | |
| Pathway | KEGG_REGULATION_OF_AUTOPHAGY | 8.47e-06 | 35 | 199 | 6 | M6382 | |
| Pathway | KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY | 1.15e-05 | 55 | 199 | 7 | M11844 | |
| Pathway | WP_INTERFERONMEDIATED_SIGNALING | 1.18e-05 | 37 | 199 | 6 | M39785 | |
| Pathway | WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE | 1.62e-05 | 39 | 199 | 6 | MM15914 | |
| Pathway | BIOCARTA_IL1R_PATHWAY | 2.19e-05 | 41 | 199 | 6 | MM1493 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | KIF26A KIF2B KIF26B CARMIL1 IFNA2 IFNA4 IFNA7 IFNA10 IFNA16 IFNA21 PRKAR2B | 2.94e-05 | 170 | 199 | 11 | M941 |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | TNFRSF10C IFNA2 IFNA4 IFNA7 IFNA10 IFNA16 IFNA21 PPP3CA PRF1 | 1.40e-04 | 137 | 199 | 9 | M5669 |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | IL17RA UVRAG VPS39 GEMIN5 IFNA2 IFNA4 IFNA7 IFNA10 IFNA16 IFNA21 NUP188 | 1.53e-04 | 204 | 199 | 11 | M45011 |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 2.43e-04 | 88 | 199 | 7 | M16004 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 3.86e-04 | 25 | 199 | 4 | MM14511 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 4.15e-04 | 126 | 199 | 8 | M45009 | |
| Pathway | KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY | 4.90e-04 | 71 | 199 | 6 | M15913 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 5.24e-04 | 27 | 199 | 4 | M12123 | |
| Pathway | REACTOME_HEMOSTASIS | BRPF3 KIF26A TRPC6 DGKB DGKG ITGA4 KIF2B GLG1 TRPC7 KIF26B CARMIL1 ADAMTS13 IFNA2 IFNA4 IFNA7 IFNA10 IFNA16 IFNA21 GUCY1A2 PRKAR2B PDE5A | 6.18e-04 | 679 | 199 | 21 | M8395 |
| Pathway | KEGG_MEDICUS_REFERENCE_DYNEIN_RECRUITMENT_TO_THE_KINETOCHORE | 7.92e-04 | 30 | 199 | 4 | M47889 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 8.11e-04 | 78 | 199 | 6 | M973 | |
| Pathway | REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA | 1.05e-03 | 82 | 199 | 6 | M1002 | |
| Pubmed | SPEG CKAP5 DGKB GPATCH8 DCAF5 PXDN SNX27 RIPOR1 BOD1L1 MCF2L PCDH10 BAIAP3 DYNC1H1 TCF20 SYNE1 DLGAP4 OBSL1 NLGN1 BTBD7 ITSN2 MACF1 ARHGEF4 SCRIB SPEN SPATA13 | 3.71e-15 | 407 | 276 | 25 | 12693553 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TBC1D9B PCNX3 MYO7A KIF26A SPEG OBSCN FYCO1 REXO1 PLEKHM1 ACOX3 FAT1 EHBP1L1 EIF4ENIF1 RIPOR1 DTX2 MCF2L CAMSAP1 UVRAG DYNC1H1 SMG6 KALRN VPS39 ZNF316 AKNA GEMIN5 MIB2 REV3L NHSL1 NADSYN1 BTBD7 TXNRD3 PCNX1 NUP188 ARHGEF4 PC SPEN SPATA13 | 1.74e-13 | 1105 | 276 | 37 | 35748872 |
| Pubmed | ANKRD31 CNST GPATCH8 ESCO1 FAT2 TCF20 DSPP SYNE1 DLGAP4 CARS1 REV3L DENND3 MACF1 NUP188 PC | 1.61e-12 | 152 | 276 | 15 | 34299191 | |
| Pubmed | 6.01e-12 | 14 | 276 | 7 | 22815848 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BDP1 HDAC4 SPTB TRPS1 NAIP OBSCN KCNIP3 SSPOP ESCO1 PLEKHM1 TASOR2 MALT1 CFAP20DC BMPR2 PXDN RIPOR1 BOD1L1 HOOK2 MCF2L BAIAP3 SMG6 CARMIL1 ROR2 TECTA FAF1 RLF HIPK3 THAP4 NADSYN1 PPP3CA LRRC1 LRP1 MACF1 PHF14 SCAF11 ARHGEF4 PNPLA7 PCDH1 KLHL26 | 6.46e-11 | 1489 | 276 | 39 | 28611215 |
| Pubmed | High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor. | 1.06e-10 | 11 | 276 | 6 | 6444699 | |
| Pubmed | Mechanism of SUMOylation-Mediated Regulation of Type I IFN Expression. | 1.06e-10 | 11 | 276 | 6 | 36681180 | |
| Pubmed | Type I interferon dependence of plasmacytoid dendritic cell activation and migration. | 1.06e-10 | 11 | 276 | 6 | 15795237 | |
| Pubmed | 1.06e-10 | 11 | 276 | 6 | 9794439 | ||
| Pubmed | 1.06e-10 | 11 | 276 | 6 | 18835032 | ||
| Pubmed | Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. | 1.06e-10 | 11 | 276 | 6 | 10448195 | |
| Pubmed | IFN-alpha can both protect against and promote the development of type 1 diabetes. | 1.06e-10 | 11 | 276 | 6 | 19120292 | |
| Pubmed | Effect of interferon-alpha on immediate early gene expression of murine cytomegalovirus. | 1.06e-10 | 11 | 276 | 6 | 8389790 | |
| Pubmed | The mouse IFN-alpha (Ifa) locus: correlation of physical and linkage maps by in situ hybridization. | 1.06e-10 | 11 | 276 | 6 | 3456887 | |
| Pubmed | 1.06e-10 | 11 | 276 | 6 | 25310498 | ||
| Pubmed | MAVS Deficiency Is Associated With a Reduced T Cell Response Upon Secondary RSV Infection in Mice. | 2.10e-10 | 12 | 276 | 6 | 33123150 | |
| Pubmed | A novel anti-viral role for STAT3 in IFN-Îą signalling responses. | 2.10e-10 | 12 | 276 | 6 | 27988795 | |
| Pubmed | 2.10e-10 | 12 | 276 | 6 | 8656058 | ||
| Pubmed | 2.10e-10 | 12 | 276 | 6 | 6188104 | ||
| Pubmed | Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice. | 2.10e-10 | 12 | 276 | 6 | 18716002 | |
| Pubmed | Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway. | 2.10e-10 | 12 | 276 | 6 | 16611902 | |
| Pubmed | 2.10e-10 | 12 | 276 | 6 | 30967261 | ||
| Pubmed | 2.10e-10 | 12 | 276 | 6 | 17434974 | ||
| Pubmed | 2.10e-10 | 12 | 276 | 6 | 8245849 | ||
| Pubmed | 2.10e-10 | 12 | 276 | 6 | 3017340 | ||
| Pubmed | Role of interferons in the regulation of cell proliferation, differentiation, and development. | 2.10e-10 | 12 | 276 | 6 | 7530016 | |
| Pubmed | 2.10e-10 | 12 | 276 | 6 | 9794206 | ||
| Pubmed | Isolation and mapping of four new DNA markers from mouse chromosome 4. | 2.10e-10 | 12 | 276 | 6 | 1360280 | |
| Pubmed | 2.10e-10 | 12 | 276 | 6 | 7601556 | ||
| Pubmed | 2.10e-10 | 12 | 276 | 6 | 16565497 | ||
| Pubmed | Regulation of effector and memory T-cell functions by type I interferon. | 2.10e-10 | 12 | 276 | 6 | 21320124 | |
| Pubmed | Evolution of the interferon alpha gene family in eutherian mammals. | 2.10e-10 | 12 | 276 | 6 | 17512142 | |
| Pubmed | Repression of the murine interferon alpha 11 gene: identification of negatively acting sequences. | 2.10e-10 | 12 | 276 | 6 | 1886773 | |
| Pubmed | The physical separation of Lps and Ifa loci in BXH recombinant inbred mice. | 2.10e-10 | 12 | 276 | 6 | 2572648 | |
| Pubmed | Developmental control of IFN-alpha expression in murine embryos. | 2.10e-10 | 12 | 276 | 6 | 7925651 | |
| Pubmed | The role of type 1 interferons in coagulation induced by gram-negative bacteria. | 2.10e-10 | 12 | 276 | 6 | 32016282 | |
| Pubmed | Multiple pathways of interferon-induced gene expression in murine macrophages. | 2.10e-10 | 12 | 276 | 6 | 7684767 | |
| Pubmed | Ligation of CD180 inhibits IFN-Îą signaling in a Lyn-PI3K-BTK-dependent manner in B cells. | 2.10e-10 | 12 | 276 | 6 | 26277892 | |
| Pubmed | 2.10e-10 | 12 | 276 | 6 | 6689487 | ||
| Pubmed | Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection. | 2.10e-10 | 12 | 276 | 6 | 22912583 | |
| Pubmed | 2.10e-10 | 12 | 276 | 6 | 23747509 | ||
| Pubmed | 2.10e-10 | 12 | 276 | 6 | 18937499 | ||
| Pubmed | Structure and expression of a new murine interferon-alpha gene: MuIFN-alpha I9. | 2.10e-10 | 12 | 276 | 6 | 3758677 | |
| Pubmed | 2.10e-10 | 12 | 276 | 6 | 19406830 | ||
| Pubmed | 2.10e-10 | 12 | 276 | 6 | 22685550 | ||
| Pubmed | 2.10e-10 | 12 | 276 | 6 | 20038206 | ||
| Pubmed | Murine alpha/beta interferons inhibit benzo(a)pyrene activation and mutagenesis in mice. | 2.10e-10 | 12 | 276 | 6 | 8304945 | |
| Pubmed | 2.10e-10 | 12 | 276 | 6 | 11846978 | ||
| Pubmed | Identification of distal silencing elements in the murine interferon-A11 gene promoter. | 2.10e-10 | 12 | 276 | 6 | 8760352 | |
| Pubmed | Behavioral effects of mouse interferons-alpha and -gamma and human interferon-alpha in mice. | 2.10e-10 | 12 | 276 | 6 | 1422836 | |
| Pubmed | 2.10e-10 | 12 | 276 | 6 | 17277125 | ||
| Pubmed | 2.10e-10 | 12 | 276 | 6 | 17451966 | ||
| Pubmed | 2.10e-10 | 12 | 276 | 6 | 25897172 | ||
| Pubmed | A polymorphic trinucleotide repeat sequence mapping to distal mouse chromosome 4. | 2.10e-10 | 12 | 276 | 6 | 8672140 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | SETX MYO7A CENPF OBSCN CKAP5 ZBTB41 SSPOP TMEM132B ESCO1 ALDH16A1 BOD1L1 PCDH10 BANK1 DYNC1H1 TCP1 KIF26B NTMT1 ZNF316 REV3L ARHGAP5 MSH6 ZZZ3 LMNB1 PHF14 NUP188 SCRIB | 2.81e-10 | 736 | 276 | 26 | 29676528 |
| Pubmed | DLGAP2 MYO7A SPTB CKAP5 DGKB NCAM1 TXN GPD1L TTC7B NMT2 PGAM4 SNX27 DYNC1H1 CPEB2 KALRN TCP1 SYNE1 CARMIL1 DLGAP4 ELP1 GEMIN5 KANK2 NHSL1 ARHGAP5 FBXL16 PPP3CA GUCY1A2 ICAM5 CPEB4 ITSN2 PRKAR2B MACF1 CTNNA2 ARHGEF4 SCRIB PC PCDH1 | 3.01e-10 | 1431 | 276 | 37 | 37142655 | |
| Pubmed | Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. | 3.87e-10 | 13 | 276 | 6 | 12930842 | |
| Pubmed | 3.87e-10 | 13 | 276 | 6 | 2471809 | ||
| Pubmed | 3.87e-10 | 13 | 276 | 6 | 8438572 | ||
| Pubmed | 3.87e-10 | 13 | 276 | 6 | 9343822 | ||
| Pubmed | 3.87e-10 | 13 | 276 | 6 | 19635904 | ||
| Pubmed | 3.87e-10 | 13 | 276 | 6 | 19706714 | ||
| Pubmed | Organization, structure and expression of murine interferon alpha genes. | 3.87e-10 | 13 | 276 | 6 | 2987810 | |
| Pubmed | 3.87e-10 | 13 | 276 | 6 | 19130550 | ||
| Pubmed | 3.87e-10 | 13 | 276 | 6 | 21469099 | ||
| Pubmed | Effects of IFN alpha on late stages of HIV-1 replication cycle. | 3.87e-10 | 13 | 276 | 6 | 9865497 | |
| Pubmed | Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. | 3.87e-10 | 13 | 276 | 6 | 2014240 | |
| Pubmed | 3.87e-10 | 13 | 276 | 6 | 18005734 | ||
| Pubmed | 3.87e-10 | 13 | 276 | 6 | 12050368 | ||
| Pubmed | Isolation and bacterial expression of a murine alpha leukocyte interferon gene. | 3.87e-10 | 13 | 276 | 6 | 6094686 | |
| Pubmed | 3.87e-10 | 13 | 276 | 6 | 2993652 | ||
| Pubmed | 3.87e-10 | 13 | 276 | 6 | 1655578 | ||
| Pubmed | 3.87e-10 | 13 | 276 | 6 | 21263073 | ||
| Pubmed | 3.87e-10 | 13 | 276 | 6 | 38660315 | ||
| Pubmed | Evidence for a different susceptibility of primate lentiviruses to type I interferons. | 3.87e-10 | 13 | 276 | 6 | 23255800 | |
| Pubmed | 3.87e-10 | 13 | 276 | 6 | 7523540 | ||
| Pubmed | 3.87e-10 | 13 | 276 | 6 | 23804712 | ||
| Pubmed | 3.87e-10 | 13 | 276 | 6 | 22431588 | ||
| Pubmed | Mouse interferon alpha and beta genes are linked at the centromere proximal region of chromosome 4. | 3.87e-10 | 13 | 276 | 6 | 3973562 | |
| Pubmed | 3.87e-10 | 13 | 276 | 6 | 22739040 | ||
| Pubmed | 3.87e-10 | 13 | 276 | 6 | 20065291 | ||
| Pubmed | 3.87e-10 | 13 | 276 | 6 | 9181467 | ||
| Pubmed | 3.87e-10 | 13 | 276 | 6 | 17723216 | ||
| Pubmed | 3.87e-10 | 13 | 276 | 6 | 20427526 | ||
| Pubmed | Sequencing and bacterial expression of a novel murine alpha interferon gene. | 3.87e-10 | 13 | 276 | 6 | 18726328 | |
| Pubmed | 3.87e-10 | 13 | 276 | 6 | 18572754 | ||
| Pubmed | 3.87e-10 | 13 | 276 | 6 | 15723075 | ||
| Pubmed | KDM4C DGKB TSPYL4 BAIAP3 SMG6 VPS39 SYNE1 IPO13 MACF1 PCNX1 PHF14 | 5.45e-10 | 101 | 276 | 11 | 9872452 | |
| Pubmed | Dual regulatory roles of phosphatidylinositol 3-kinase in IFN signaling. | 6.74e-10 | 14 | 276 | 6 | 18981154 | |
| Pubmed | Interferon induction by HIV glycoprotein 120: role of the V3 loop. | 6.74e-10 | 14 | 276 | 6 | 7526537 | |
| Pubmed | 6.74e-10 | 14 | 276 | 6 | 19559726 | ||
| Pubmed | Differential constitutive expression of interferon genes in early mouse embryos. | 6.74e-10 | 14 | 276 | 6 | 7654369 | |
| Pubmed | 6.74e-10 | 14 | 276 | 6 | 2552026 | ||
| Pubmed | Modulation of interferon-mediated inhibition of human immunodeficiency virus type 1 by Tat. | 6.74e-10 | 14 | 276 | 6 | 7532202 | |
| Pubmed | 6.74e-10 | 14 | 276 | 6 | 18200012 | ||
| Pubmed | Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. | 6.74e-10 | 14 | 276 | 6 | 18200009 | |
| Pubmed | A structural basis for interferon-alpha-receptor interactions. | 6.74e-10 | 14 | 276 | 6 | 17517919 | |
| Pubmed | 6.74e-10 | 14 | 276 | 6 | 25972534 | ||
| Pubmed | 6.74e-10 | 14 | 276 | 6 | 7583919 | ||
| Pubmed | 6.74e-10 | 14 | 276 | 6 | 2987811 | ||
| Interaction | TOP3B interactions | TBC1D9B HDAC4 PCNX3 MYO7A CENPF KIF26A SPEG SPTB OBSCN FYCO1 UNC45A REXO1 PLEKHM1 ACOX3 FAT1 EHBP1L1 EIF4ENIF1 RIPOR1 DTX2 MCF2L CAMSAP1 UVRAG DYNC1H1 SMG6 KALRN VPS39 ZNF316 AKNA GEMIN5 MIB2 REV3L KANK2 NHSL1 NADSYN1 BTBD7 TRIM56 CPEB4 TXNRD3 PCNX1 NUP188 ARHGEF4 PC SPEN SPATA13 | 4.93e-07 | 1470 | 272 | 44 | int:TOP3B |
| Interaction | COMTD1 interactions | KNTC1 TBC1D9B SETX CKAP5 FANCD2 COG1 ANKRD28 HOOK2 XPO4 GEMIN5 FBXL16 LRRC1 NUP188 | 3.47e-06 | 200 | 272 | 13 | int:COMTD1 |
| Interaction | KCTD13 interactions | ZMYND19 DLGAP2 MYO7A SPTB CKAP5 DGKB NCAM1 TXN GPD1L TTC7B NMT2 SNX27 DYNC1H1 CPEB2 KALRN TCP1 SYNE1 CARMIL1 DLGAP4 ELP1 GEMIN5 KANK2 FAF1 NHSL1 ARHGAP5 FBXL16 PPP3CA GUCY1A2 ICAM5 CPEB4 ITSN2 PRKAR2B MACF1 CTNNA2 ARHGEF4 SCRIB PC PCDH1 PCNA | 1.18e-05 | 1394 | 272 | 39 | int:KCTD13 |
| Cytoband | 9p22 | 7.19e-09 | 25 | 276 | 6 | 9p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9p21 | 6.99e-08 | 124 | 276 | 9 | chr9p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q34 | ZMYND19 SETX NOXA1 HMCN2 CIZ1 CAMSAP1 NTMT1 ADAMTS13 NUP188 PNPLA7 | 3.15e-05 | 325 | 276 | 10 | chr9q34 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | SPEG OBSCN NCAM1 PXDN HMCN2 SDK1 ADAMTSL1 KALRN NTRK2 ROR2 OBSL1 LINGO2 ROBO2 MYBPC2 | 1.32e-09 | 161 | 187 | 14 | 593 |
| GeneFamily | Interferons | 8.19e-07 | 32 | 187 | 6 | 598 | |
| GeneFamily | Cadherin related | 2.37e-05 | 17 | 187 | 4 | 24 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.13e-05 | 66 | 187 | 6 | 722 | |
| GeneFamily | EF-hand domain containing | 9.69e-05 | 219 | 187 | 10 | 863 | |
| GeneFamily | PRAME family | 1.00e-04 | 24 | 187 | 4 | 686 | |
| GeneFamily | Ankyrin repeat domain containing | ANKRD31 ILK ANKRD28 BANK1 MIB2 ANKRD50 KANK2 ANKRD30A MPHOSPH8 ANKS3 | 2.19e-04 | 242 | 187 | 10 | 403 |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 5.04e-04 | 36 | 187 | 4 | 823 | |
| GeneFamily | Fibronectin type III domain containing | 1.40e-03 | 160 | 187 | 7 | 555 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_5 | 5.00e-07 | 29 | 276 | 6 | MM586 | |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NAIVE_NOT_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 3.15e-06 | 39 | 276 | 6 | M41095 | |
| Coexpression | GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP | SETX MYO7A CENPF FANCD2 TTC7B REV3L NADSYN1 SHCBP1 IPO13 SCRIB GFM1 | 5.12e-06 | 187 | 276 | 11 | M6807 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | KNTC1 CENPF FANCD2 CFAP20DC FAT1 ANKRD28 CASP8AP2 E2F8 RFWD3 GSR MSH6 LMNB1 SHCBP1 CDK5RAP2 MTBP PCNA | 6.47e-06 | 402 | 276 | 16 | MM454 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | BDP1 UBR1 GGNBP2 SETX MYO7A TRPS1 GPATCH8 ITGA4 DCAF5 MALT1 GLG1 ANKRD28 BOD1L1 IL17RA TAP2 DYNC1H1 USP47 TCP1 SYNE1 RNF149 AKNA ELP1 XPO4 REV3L CARD8 CCND2 PRF1 ITSN2 MYLIP MACF1 PCNX1 MPHOSPH8 SCAF11 SPEN SPATA13 | 7.99e-06 | 1492 | 276 | 35 | M40023 |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_UP | 8.34e-06 | 27 | 276 | 5 | M40935 | |
| Coexpression | PARENT_MTOR_SIGNALING_UP | TBC1D9B DCTN5 TNFRSF10C UNC45A TBC1D8B ACOX3 OSGEPL1 GLG1 USP47 SYNE1 CLSTN1 FAF1 NBAS NADSYN1 PPP3CA TXNRD3 LRP1 NUP188 SCRIB | 1.05e-05 | 567 | 276 | 19 | M16909 |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 2.71e-05 | 34 | 276 | 5 | M41094 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_UP | 3.79e-05 | 87 | 276 | 7 | MM652 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | BDP1 MYO7A SPEG NCAM1 SSPOP TMEM132B RYR2 GPD1L FAT2 BOD1L1 MCF2L TSPYL4 WNK3 CPEB2 ZCCHC12 ENOX1 THSD7A NLGN1 REV3L SIX3 FBXL16 CPEB4 PRKAR2B ROBO2 CTNNA2 PCDH1 SPATA13 | 4.77e-05 | 1106 | 276 | 27 | M39071 |
| Coexpression | GSE27786_NKCELL_VS_NEUTROPHIL_DN | ARHGAP42 GGNBP2 MCF2L BANK1 USP47 CPEB2 E2F8 ICAM5 RP2 PNPLA7 | 5.54e-05 | 200 | 276 | 10 | M4859 |
| Coexpression | GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_UP | BRPF3 CNST ZBTB41 BMPR2 DNAJC28 GLG1 CD93 PRKAR2B PDE5A SPATA13 | 5.54e-05 | 200 | 276 | 10 | M7294 |
| Coexpression | GSE18893_TCONV_VS_TREG_24H_CULTURE_DN | CENPF TRPS1 PLEKHM1 BMPR2 CASP7 ANKRD50 CD93 SHCBP1 SCAF11 IAH1 | 5.54e-05 | 200 | 276 | 10 | M7289 |
| Coexpression | ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN | DLGAP2 DCHS2 TRMT10B CENPF OBSCN DGKB DGKG CCDC178 MALT1 FAT2 PXDN TDRD6 PIPSL SDK1 THEMIS2 TRPC7 KALRN KIF26B AKNA LINGO2 ADAMTS13 DENND3 ANKRD30A | 5.72e-05 | 873 | 276 | 23 | M16009 |
| Coexpression | GABRIELY_MIR21_TARGETS | CEMIP2 BMPR2 ANKRD28 WNK3 USP47 AHSA2P REV3L POLR3B BTBD7 ITSN2 SCAF11 RP2 | 6.24e-05 | 289 | 276 | 12 | M2196 |
| Coexpression | SANSOM_APC_TARGETS | PRAMEF5 DGKB PRAMEF6 ROR2 PRAMEF20 RNF149 ELP1 PRAMEF12 CCND2 TXNRD3 CDK5RAP2 | 6.28e-05 | 245 | 276 | 11 | MM735 |
| Coexpression | GROSS_HYPOXIA_VIA_HIF1A_DN | 7.73e-05 | 131 | 276 | 8 | MM1127 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP | XPO4 GEMIN5 IFNA2 IFNA4 IFNA7 IFNA10 IFNA16 IFNA21 LMNB1 IPO13 | 8.32e-05 | 210 | 276 | 10 | MM751 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SETX HDAC4 CENPF KDM4C CKAP5 GPATCH8 MALT1 FAT1 NMT2 ARHGAP29 ANKRD28 UVRAG REV3L RLF NBAS MSH6 ZZZ3 LMNB1 ITSN2 MACF1 PHF14 SPEN | 1.19e-04 | 856 | 276 | 22 | M4500 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | KNTC1 CENPF TRPC6 TRPS1 NCAM1 ITGA4 TBC1D8B FANCD2 FAT1 ALDH1A2 PXDN WNK3 TCP1 KIF26B OBSL1 ZNF521 ZDBF2 REV3L ANKRD50 LMNB1 GUCY1A2 SHCBP1 LRP1 PRKAR2B ROBO2 PDE5A | 4.31e-06 | 768 | 265 | 26 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | TRPC6 NCAM1 ITGA4 TBC1D8B ALDH1A2 KIF26B ZNF521 ZDBF2 ANKRD50 LMNB1 GUCY1A2 SHCBP1 LRP1 ROBO2 PDE5A | 8.97e-06 | 310 | 265 | 15 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | SETX LARP6 KIF26A TRPS1 ITGA4 RYR2 CAMSAP1 PCDH10 CPEB2 ADAMTSL1 THSD7A KALRN KIF26B NTRK2 ROR2 REV3L KANK2 ZFX CCND2 HIPK3 CD93 FBXL16 PPP3CA LMNB1 CPEB4 PDE5A | 1.31e-05 | 818 | 265 | 26 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | ARHGAP42 MYH8 SETX HDAC4 KIF26A SPEG TRPS1 GPATCH8 ITGA4 ALDH1A2 CAMSAP1 PCDH10 THSD7A KALRN KIF26B ROR2 ZNF316 REV3L KANK2 ZFX CCND2 HIPK3 CD93 LMNB1 PDE5A | 2.90e-05 | 806 | 265 | 25 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | ARHGAP42 SETX HDAC4 KIF26A SPEG TRPS1 GPATCH8 CAMSAP1 REV3L KANK2 ZFX CCND2 HIPK3 LMNB1 | 4.10e-05 | 312 | 265 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | ARHGAP42 CENPF TRPC6 TRPS1 NCAM1 ZBTB41 ITGA4 TBC1D8B FAT1 ALDH1A2 PXDN WNK3 KIF26B OBSL1 ZDBF2 REV3L ANKRD50 E2F8 LMNB1 GUCY1A2 LRP1 PRKAR2B ROBO2 PDE5A | 4.14e-05 | 773 | 265 | 24 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | TRPS1 NCAM1 ITGA4 TBC1D8B FAT1 ALDH1A2 WNK3 OBSL1 ZNF521 ZDBF2 REV3L LRP1 PRKAR2B ROBO2 PDE5A | 5.78e-05 | 364 | 265 | 15 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | TRPC6 TRPS1 NCAM1 ALDH1A2 KLHL7 KALRN KIF26B ZDBF2 CCND2 LMNB1 GUCY1A2 SHCBP1 LRP1 ROBO2 | 9.35e-05 | 337 | 265 | 14 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | ZMYND19 KNTC1 SETX CENPF GPATCH8 ZNF235 ESCO1 TASOR2 FANCD2 CFAP20DC NMT2 MED12L SNX27 GCA DNAH8 WNK3 CPEB2 CASP8AP2 TCP1 FAF1 RFWD3 PRKAR2B PDE5A NUP188 | 1.03e-04 | 820 | 265 | 24 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | CENPF TRPC6 TRPS1 NCAM1 ALDH1A2 PXDN KLHL7 ARHGAP29 WNK3 CASP8AP2 TRPC7 KALRN TCP1 KIF26B OBSL1 ZNF521 ZDBF2 REV3L CCND2 LMNB1 GUCY1A2 SHCBP1 LRP1 ROBO2 | 1.18e-04 | 827 | 265 | 24 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.76e-04 | 233 | 265 | 11 | gudmap_developingGonad_e12.5_ovary_k5_1000 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | TRPS1 DGKG RYR2 CEMIP2 GPD1L MALT1 ALDH1A2 ENOX1 CARMIL1 ZNF521 CCND2 CTNNA2 | 1.40e-09 | 179 | 276 | 12 | 14fc8ccb6b215063d747643f47d780d2b237eb67 |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | BRPF3 TRPS1 DGKG CEMIP2 MALT1 ALDH1A2 ENOX1 CARMIL1 ZNF521 CCND2 GUCY1A2 CTNNA2 | 1.69e-09 | 182 | 276 | 12 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | ARHGAP42 SPEG SPTB TRPC6 DGKB DGKG RYR2 FAT1 PXDN ENOX1 KALRN GUCY1A2 | 2.92e-09 | 191 | 276 | 12 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | ARHGAP42 SPTB TRPC6 OBSCN DGKG RYR2 FAT1 INSC KANK2 GUCY1A2 PRKAR2B PDE5A | 4.92e-09 | 200 | 276 | 12 | 12326cc6f0af24bacba9493dc79e7c7347db2f41 |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | ARHGAP42 SPTB TRPC6 OBSCN DGKG RYR2 FAT1 INSC KANK2 GUCY1A2 PRKAR2B PDE5A | 4.92e-09 | 200 | 276 | 12 | 362706445edb33b313684efe50b1f44f5f816e67 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | ARHGAP42 SPTB TRPC6 DGKB DGKG ITGA4 RYR2 FAT1 ALDH1A2 ENOX1 GUCY1A2 | 1.26e-08 | 174 | 276 | 11 | 015d3742d3d79a57413a333f00ef2d380a9848dd |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | SPEG TRPC6 DGKG RYR2 FAT1 SDK1 NRIP2 KALRN SYNE1 KANK2 GUCY1A2 | 2.51e-08 | 186 | 276 | 11 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ARHGAP42 SPEG TRPC6 DGKG TMEM132B RYR2 FAT1 SYNE1 KANK2 GUCY1A2 PDE5A | 3.30e-08 | 191 | 276 | 11 | 08042952431ca1a6fd7dfc13f36eb28643979598 |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | KNTC1 UBR1 IL12RB2 ITGA4 CEMIP2 GLG1 XPO4 NBAS ZZZ3 MACF1 SPEN | 3.30e-08 | 191 | 276 | 11 | 9454f642c3621370fa23640b631301346b300950 |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | KNTC1 CENPF SPTB CKAP5 ITGA4 FANCD2 POLE2 E2F8 RFWD3 LMNB1 SHCBP1 | 4.08e-08 | 195 | 276 | 11 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ARHGAP42 TRPC6 OBSCN DGKG RYR2 TTC7B INSC ENOX1 PRAMEF20 GUCY1A2 PRKAR2B | 4.53e-08 | 197 | 276 | 11 | f66945f9007d59d4208849c7fd727f8519713fbc |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ARHGAP42 RDH8 SPTB TRPC6 OBSCN DGKG RYR2 INSC ENOX1 GUCY1A2 PRKAR2B | 5.03e-08 | 199 | 276 | 11 | 854628ce91068093c14bd4d45ba38c41469f3549 |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ARHGAP42 TMEM132B FAT1 INSC SYNE1 ADAMTS13 KANK2 QPRT LRP1 ROBO2 PDE5A | 5.03e-08 | 199 | 276 | 11 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | BMPR2 ARHGAP29 TAP2 CASP8AP2 SYNE1 ARHGAP5 BTBD7 CPEB4 ITSN2 SCAF11 | 1.77e-07 | 178 | 276 | 10 | 01dafd19de04eff459253eaa9a35debf8f3deedf |
| ToppCell | Pericytes-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | SPEG SPTB DGKB DGKG NRIP2 ADAMTSL1 NTRK2 KANK2 GUCY1A2 PDE5A | 2.17e-07 | 182 | 276 | 10 | 46c213597445b1f4f09dc367f27702d24b201daf |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.21e-07 | 139 | 276 | 9 | 505bf5a483fc2ba69377db9850c3b26ab2f416d1 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor | ARHGAP42 SPTB TRPC6 OBSCN DGKG KCNIP3 RYR2 INSC ENOX1 GUCY1A2 | 2.28e-07 | 183 | 276 | 10 | fc31a43a637423cb3bb9aa184a3a889a0b9aaea6 |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | ARHGAP42 SPTB TRPC6 OBSCN DGKG KCNIP3 RYR2 INSC ENOX1 GUCY1A2 | 2.79e-07 | 187 | 276 | 10 | 62759efb660179402fb574ce5701c89a2e17bcfe |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 3.23e-07 | 190 | 276 | 10 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.23e-07 | 190 | 276 | 10 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ARHGAP42 SPEG TRPC6 DGKG RYR2 FAT1 SYNE1 KANK2 GUCY1A2 PDE5A | 3.39e-07 | 191 | 276 | 10 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 3.39e-07 | 191 | 276 | 10 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.39e-07 | 191 | 276 | 10 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CEMIP2 BMPR2 PXDN ARHGAP29 RIPOR1 MCF2L CLSTN1 DENND3 CD93 PCDH1 | 3.92e-07 | 194 | 276 | 10 | f159ef8541d75a4e98468947f231bb463bec922c |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | ARHGAP42 TRPC6 THSD7A KALRN CARMIL1 ROR2 ZNF521 NLGN1 MACF1 ROBO2 | 4.10e-07 | 195 | 276 | 10 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ARHGAP42 TRPC6 OBSCN DGKG RYR2 INSC ENOX1 PRAMEF20 GUCY1A2 PRKAR2B | 4.51e-07 | 197 | 276 | 10 | 41dd312f46a2b983c8d864adeb6970c0ca4a8048 |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | ARHGAP42 TRPC6 FAT1 INSC ADAMTS13 KANK2 QPRT LRP1 ROBO2 PDE5A | 4.95e-07 | 199 | 276 | 10 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ARHGAP42 RDH8 TRPC6 OBSCN DGKG RYR2 INSC ENOX1 GUCY1A2 PRKAR2B | 4.95e-07 | 199 | 276 | 10 | 929f809579368201331d9099d8904b6e3c41797b |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | ARHGAP42 TRPC6 OBSCN DGKG RYR2 FAT1 INSC GUCY1A2 PDE5A PCDH1 | 5.18e-07 | 200 | 276 | 10 | 0c648941447c738caf62f2d71e296d6cca492c8b |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | ARHGAP42 TRPC6 OBSCN DGKG RYR2 FAT1 INSC GUCY1A2 PDE5A PCDH1 | 5.18e-07 | 200 | 276 | 10 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | ARHGAP42 TRPC6 OBSCN DGKG RYR2 FAT1 INSC GUCY1A2 PDE5A PCDH1 | 5.18e-07 | 200 | 276 | 10 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | ARHGAP42 TRPC6 RYR2 FAT1 SYNE1 KANK2 GUCY1A2 QPRT LRP1 PDE5A | 5.18e-07 | 200 | 276 | 10 | 5ed4261157cd51109b314818133ac3a0d34ee5fa |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.04e-06 | 167 | 276 | 9 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.26e-06 | 171 | 276 | 9 | adbcfa4bf6bc1c604535a24435924cdb091e2dd7 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 1.26e-06 | 171 | 276 | 9 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 1.33e-06 | 172 | 276 | 9 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.33e-06 | 172 | 276 | 9 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-06 | 174 | 276 | 9 | 6c36d607c48267a75ab4da6fb2fe3f931d1b3b52 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-06 | 175 | 276 | 9 | 316f2ea930437bf1243b1c0f45e6bd864112c6f2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-06 | 175 | 276 | 9 | a9f08e1e4c2997dcdd3e5d92daac480da19100b8 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.68e-06 | 177 | 276 | 9 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.68e-06 | 177 | 276 | 9 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 1.68e-06 | 177 | 276 | 9 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.68e-06 | 177 | 276 | 9 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.68e-06 | 177 | 276 | 9 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.76e-06 | 178 | 276 | 9 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-06 | 179 | 276 | 9 | 36ad18f52e175ab636ceaa3be81212fa362c96c1 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-06 | 179 | 276 | 9 | bfc226bcf0b93525992344f968268a261d86fcbf | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-06 | 180 | 276 | 9 | a37cc885fe3f6cb9df69d43358064c83c18412e7 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-06 | 180 | 276 | 9 | 63a6d532b16b8b15c7c9102148d7297ee3afd641 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-06 | 184 | 276 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.32e-06 | 184 | 276 | 9 | 7128a2be291544d3df3ed6c80f21ddda8437dcba | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-06 | 184 | 276 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.32e-06 | 184 | 276 | 9 | 55dde9c4eebac2a33788c1ff1d8fe312d150fad4 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-06 | 184 | 276 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.32e-06 | 184 | 276 | 9 | d14238f7b0b55a4c8d7040bea854bd221a66ac30 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-06 | 184 | 276 | 9 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.53e-06 | 186 | 276 | 9 | 8915436d09775f2828a7678af203b1082b36e21c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.53e-06 | 186 | 276 | 9 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.64e-06 | 187 | 276 | 9 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 2.64e-06 | 187 | 276 | 9 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | CEMIP2 ARHGAP29 MCF2L ADAMTSL1 THSD7A KALRN ZNF521 CD93 LRRC1 | 2.76e-06 | 188 | 276 | 9 | d582b76fc2faac526c9bf97503041129e1a6a211 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.76e-06 | 188 | 276 | 9 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.76e-06 | 188 | 276 | 9 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.76e-06 | 188 | 276 | 9 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.89e-06 | 189 | 276 | 9 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.89e-06 | 189 | 276 | 9 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-NK_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.89e-06 | 189 | 276 | 9 | 5a9c3c61998efc40a5d2042e0f568b52103734a9 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.89e-06 | 189 | 276 | 9 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.89e-06 | 189 | 276 | 9 | 9c2492c38f27e4c699b40680652e4c64911cce52 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.01e-06 | 190 | 276 | 9 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.01e-06 | 190 | 276 | 9 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.01e-06 | 190 | 276 | 9 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.01e-06 | 190 | 276 | 9 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.15e-06 | 191 | 276 | 9 | 7edc22e7e70697fb22690699efb352577162709b | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-06 | 191 | 276 | 9 | 60bc1f3efa7bbad5cb7944fe5e049ea79cd1745a | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-06 | 192 | 276 | 9 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | Control-Fibroblasts-Vascular_smooth_muscle|Control / group, cell type (main and fine annotations) | 3.42e-06 | 193 | 276 | 9 | 60e44aac8be0430ad35e20eb98b1b700d76a0427 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.42e-06 | 193 | 276 | 9 | bbdfda6665941cfa1965418bb91ef9ff43b1326f | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.57e-06 | 194 | 276 | 9 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.57e-06 | 194 | 276 | 9 | 590a9d4f054e6a3685daf752c9354650fcc7d18a | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | 3.57e-06 | 194 | 276 | 9 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.57e-06 | 194 | 276 | 9 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | Control-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 3.73e-06 | 195 | 276 | 9 | 6687e579582d7a239bee80846de0cf827a6f6a62 | |
| ToppCell | COPD-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 3.88e-06 | 196 | 276 | 9 | c9bdd505c3ab380ed7b272aa518df31a0a706a06 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.05e-06 | 197 | 276 | 9 | 3332b9b5bf78f0203ebbd94257a36e9054d896c3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.22e-06 | 198 | 276 | 9 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.22e-06 | 198 | 276 | 9 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.22e-06 | 198 | 276 | 9 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.22e-06 | 198 | 276 | 9 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 4.39e-06 | 199 | 276 | 9 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.39e-06 | 199 | 276 | 9 | ad75e5e26c37a97331164d7f77235ebd9a933a44 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.39e-06 | 199 | 276 | 9 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.39e-06 | 199 | 276 | 9 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.39e-06 | 199 | 276 | 9 | b768496381362f9a2706e0892b5a7a0db82e09ce | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.58e-06 | 200 | 276 | 9 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.58e-06 | 200 | 276 | 9 | 4e1e19214aeebbdca004de7faaf4cc9d18498591 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 4.58e-06 | 200 | 276 | 9 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 4.58e-06 | 200 | 276 | 9 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.58e-06 | 200 | 276 | 9 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 7.52e-06 | 49 | 161 | 7 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Drug | Hiltonol | 7.04e-09 | 23 | 274 | 7 | CID000431963 | |
| Drug | barium iodide | 2.05e-08 | 4 | 274 | 4 | CID000083684 | |
| Drug | B132 | 1.02e-07 | 5 | 274 | 4 | CID002734031 | |
| Drug | HCV-371 | 3.02e-07 | 6 | 274 | 4 | CID003013096 | |
| Drug | AC1L9FQV | 6.32e-07 | 82 | 274 | 9 | CID000444118 | |
| Drug | Yfrkd | 6.98e-07 | 7 | 274 | 4 | CID000129984 | |
| Drug | glycrrhizin | 9.51e-07 | 86 | 274 | 9 | CID000003495 | |
| Drug | AC1LAD6M | 1.38e-06 | 8 | 274 | 4 | CID000511663 | |
| Drug | 1hiv | 1.38e-06 | 8 | 274 | 4 | CID005479205 | |
| Drug | Chebi:36708 | 1.38e-06 | 8 | 274 | 4 | CID011966289 | |
| Drug | O4-[3-[(1S)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] O1-[3-[(1R)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] (Z)-2-chlorobut-2-enedioate | 1.38e-06 | 8 | 274 | 4 | CID010011375 | |
| Drug | lomustine | 2.00e-06 | 32 | 274 | 6 | CID000003950 | |
| Drug | Telaprevir | 2.47e-06 | 9 | 274 | 4 | CID003010818 | |
| Drug | boceprevir | 2.47e-06 | 9 | 274 | 4 | CID010324367 | |
| Drug | pipobroman | 4.07e-06 | 10 | 274 | 4 | CID000004842 | |
| Drug | AC1O3GBZ | 4.14e-06 | 36 | 274 | 6 | CID006327751 | |
| Drug | Quinethazone [73-49-4]; Down 200; 13.8uM; PC3; HT_HG-U133A | SETX TBC1D8B THEMIS2 ERO1B ELP1 NLGN1 BTBD7 PRF1 MYLIP LRP1 PHF14 PCDH1 | 5.39e-06 | 198 | 274 | 12 | 3793_DN |
| Drug | fotemustine | 5.75e-06 | 38 | 274 | 6 | CID000104799 | |
| Drug | flesinoxan | 6.34e-06 | 11 | 274 | 4 | CID000057347 | |
| Drug | SC-57099B | 6.34e-06 | 11 | 274 | 4 | CID000178079 | |
| Drug | casopitant | 9.41e-06 | 12 | 274 | 4 | CID009917021 | |
| Drug | R 842 | 1.35e-05 | 13 | 274 | 4 | CID000130714 | |
| Drug | Lanicemine | 1.87e-05 | 14 | 274 | 4 | CID003038485 | |
| Drug | gunacin | 1.87e-05 | 14 | 274 | 4 | CID000198547 | |
| Drug | pppA2'-5'A2'-5'A | 2.52e-05 | 15 | 274 | 4 | CID000125229 | |
| Drug | AC1L1GVK | 3.65e-05 | 76 | 274 | 7 | CID000003860 | |
| Drug | 2',3'-dideoxycytidine (ddC | 3.65e-05 | 76 | 274 | 7 | CID000005718 | |
| Drug | YNK01 | 4.32e-05 | 17 | 274 | 4 | CID000084071 | |
| Drug | p203 | 5.50e-05 | 18 | 274 | 4 | CID000019228 | |
| Drug | podophyllin | 5.50e-05 | 18 | 274 | 4 | CID011979494 | |
| Drug | Nyco | 5.50e-05 | 18 | 274 | 4 | CID000071618 | |
| Drug | Antigens, Polyomavirus Transforming | ZMYND19 KNTC1 SETX CENPF TRPS1 COG1 USP47 ERO1B TCF20 POLE2 XPO4 E2F8 ZFX RLF THAP4 ARHGAP5 LMNB1 MTBP RP2 NUP188 PCNA | 6.50e-05 | 668 | 274 | 21 | ctd:D000952 |
| Drug | MCNU | 6.76e-05 | 36 | 274 | 5 | CID000071741 | |
| Drug | FMAU | 7.74e-05 | 37 | 274 | 5 | CID000072327 | |
| Drug | 2-[amino-[(2R,3R)-4-(dibenzylamino)-3-hydroxy-4-oxo-2-sulfanylbutanoyl]amino]acetic acid | 7.74e-05 | 37 | 274 | 5 | CID016040231 | |
| Drug | Ciluprevir [USAN] | 8.54e-05 | 20 | 274 | 4 | CID006450803 | |
| Drug | val-mCyd | 8.54e-05 | 20 | 274 | 4 | CID006918726 | |
| Drug | N3RdUMP | 9.23e-05 | 8 | 274 | 3 | CID006439282 | |
| Disease | Malignant neoplasm of breast | TBC1D9B HDAC4 CENPF OBSCN DGKG KCNIP3 TXN BMPR2 ARHGAP29 BOD1L1 THEMIS2 KALRN TCP1 VPS39 SYNE1 AHSA2P RNF149 ELP1 CASP7 TECTA IFNA2 MSH6 GUCY1A2 ICAM5 ITSN2 ANKRD30A MACF1 ARHGEF4 SPEN | 1.52e-07 | 1074 | 265 | 29 | C0006142 |
| Disease | complex cortical dysplasia with other brain malformations (is_implicated_in) | 2.85e-06 | 4 | 265 | 3 | DOID:0090131 (is_implicated_in) | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 3.88e-05 | 8 | 265 | 3 | DOID:0050753 (implicated_via_orthology) | |
| Disease | anxiety disorder | 1.45e-04 | 30 | 265 | 4 | EFO_0006788 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.48e-04 | 12 | 265 | 3 | DOID:11726 (implicated_via_orthology) | |
| Disease | Lymphoma, Non-Hodgkin | 1.88e-04 | 32 | 265 | 4 | C0024305 | |
| Disease | Anemia, Hemolytic, Acquired | 1.92e-04 | 13 | 265 | 3 | C0002879 | |
| Disease | Anemia, Hemolytic | 1.92e-04 | 13 | 265 | 3 | C0002878 | |
| Disease | Anemia, Microangiopathic | 1.92e-04 | 13 | 265 | 3 | C0002889 | |
| Disease | Microangiopathic hemolytic anemia | 1.92e-04 | 13 | 265 | 3 | C0221021 | |
| Disease | osteoarthritis | 1.93e-04 | 222 | 265 | 9 | MONDO_0005178 | |
| Disease | risk-taking behaviour | CAAP1 KIF26A TRPC6 NCAM1 TMEM132B RYR2 GLG1 SDK1 BANK1 TCF20 NTRK2 NLGN1 REV3L SIX3 MSH6 CPEB4 CTNNA2 PC | 2.10e-04 | 764 | 265 | 18 | EFO_0008579 |
| Disease | osteoarthritis, hand | 3.33e-04 | 37 | 265 | 4 | EFO_1000789 | |
| Disease | infant expressive language ability | 3.68e-04 | 16 | 265 | 3 | EFO_0006316 | |
| Disease | Cannabis use | 3.68e-04 | 16 | 265 | 3 | EFO_0007585 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | KIF26A NCAM1 TMEM132B RYR2 CEMIP2 BMPR2 KIF2B SDK1 SMG6 TCF20 ELP1 LINGO2 NLGN1 REV3L MSH6 CPEB4 ROBO2 CTNNA2 | 3.70e-04 | 801 | 265 | 18 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | susceptibility to mononucleosis measurement | 3.96e-04 | 69 | 265 | 5 | EFO_0008403 | |
| Disease | Amyotrophic lateral sclerosis | 4.44e-04 | 17 | 265 | 3 | cv:C0002736 | |
| Disease | amino acid measurement | DLGAP2 CAAP1 SETX HDAC4 DGKB TGM5 RYR2 CFAP20DC PXDN KIF2B ENOX1 SYNE1 CARMIL1 LINGO2 NLGN1 NBAS | 4.61e-04 | 678 | 265 | 16 | EFO_0005134 |
| Disease | coffee consumption measurement, Cannabis use | 4.76e-04 | 4 | 265 | 2 | EFO_0006781, EFO_0007585 | |
| Disease | Testicular Diseases | 4.76e-04 | 4 | 265 | 2 | C0039584 | |
| Disease | arthrogryposis multiplex congenita (is_implicated_in) | 4.76e-04 | 4 | 265 | 2 | DOID:0080954 (is_implicated_in) | |
| Disease | Juvenile Spinal Muscular Atrophy | 4.76e-04 | 4 | 265 | 2 | C0152109 | |
| Disease | nephrotic syndrome type 20 (implicated_via_orthology) | 4.76e-04 | 4 | 265 | 2 | DOID:0070357 (implicated_via_orthology) | |
| Disease | Muscular Atrophy, Spinal, Type II | 4.76e-04 | 4 | 265 | 2 | C0393538 | |
| Disease | Muscular atrophy, spinal, infantile chronic form | 4.76e-04 | 4 | 265 | 2 | C2931358 | |
| Disease | HMN (Hereditary Motor Neuropathy) Proximal Type I | 4.76e-04 | 4 | 265 | 2 | C0043116 | |
| Disease | Alzheimer disease | ANKRD31 TGM5 FANCD2 ALDH1A2 MED12L SDK1 BANK1 LINGO2 DENND3 UNC5CL TRIM56 PCNX1 CTNNA2 | 4.88e-04 | 485 | 265 | 13 | MONDO_0004975 |
| Disease | Tourette syndrome, schizophrenia | 5.29e-04 | 18 | 265 | 3 | EFO_0004895, MONDO_0005090 | |
| Disease | aspartate aminotransferase measurement | ANKRD31 BDP1 TBC1D9B MYO7A OBSCN FYCO1 PLEKHM1 ALDH1A2 HMCN2 ARHGAP29 BANK1 SMG6 THSD7A KALRN NTRK2 CARMIL1 AKNA PCDHGB4 CTNNA2 | 5.77e-04 | 904 | 265 | 19 | EFO_0004736 |
| Disease | PR interval | PCNX3 OBSCN DGKB RYR2 PRPS1L1 BMPR2 FAT1 KALRN CARMIL1 XPO4 FAF1 CD93 MACF1 | 5.90e-04 | 495 | 265 | 13 | EFO_0004462 |
| Disease | bilirubin measurement | UBR1 DCHS2 SPTB NEU2 UVRAG SMG6 CARMIL1 CARS1 NLGN1 REV3L ANKRD50 CCND2 | 7.14e-04 | 442 | 265 | 12 | EFO_0004570 |
| Disease | coagulation factor measurement | 7.29e-04 | 20 | 265 | 3 | EFO_0004634 | |
| Disease | level of Phosphatidylcholine (O-16:0_16:1) in blood serum | 7.89e-04 | 5 | 265 | 2 | OBA_2045112 | |
| Disease | Lymphoma, Diffuse | 8.45e-04 | 21 | 265 | 3 | C3714542 | |
| Disease | Low Grade Lymphoma (neoplasm) | 8.45e-04 | 21 | 265 | 3 | C0079747 | |
| Disease | Lymphoma, Intermediate-Grade | 8.45e-04 | 21 | 265 | 3 | C0079741 | |
| Disease | High Grade Lymphoma (neoplasm) | 8.45e-04 | 21 | 265 | 3 | C0079740 | |
| Disease | Diffuse Mixed-Cell Lymphoma | 8.45e-04 | 21 | 265 | 3 | C0079757 | |
| Disease | Lymphoma, Undifferentiated | 8.45e-04 | 21 | 265 | 3 | C0024306 | |
| Disease | Reticulosarcoma | 8.45e-04 | 21 | 265 | 3 | C0024302 | |
| Disease | Lymphoma, Mixed-Cell | 8.45e-04 | 21 | 265 | 3 | C0024304 | |
| Disease | Lymphoma, Non-Hodgkin, Familial | 9.72e-04 | 22 | 265 | 3 | C4721532 | |
| Disease | Lymphoma, Small Noncleaved-Cell | 9.72e-04 | 22 | 265 | 3 | C0079770 | |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 1.18e-03 | 6 | 265 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | cerebral cortex growth measurement | 1.18e-03 | 6 | 265 | 2 | EFO_0009328 | |
| Disease | Lissencephaly | 1.18e-03 | 6 | 265 | 2 | C0266463 | |
| Disease | diet measurement | DLGAP2 DGKG NCAM1 GPATCH8 SLC22A17 PLEKHM1 PCDH10 SDK1 TCF20 KIF26B CARMIL1 ZNF521 LINGO2 NLGN1 NBAS MSH6 TRIM56 PCDHGB4 ROBO2 CTNNA2 | 1.37e-03 | 1049 | 265 | 20 | EFO_0008111 |
| Disease | Left ventricular mass to end-diastolic volume ratio | 1.42e-03 | 25 | 265 | 3 | EFO_0010556 | |
| Disease | Pulmonary Hypertension, Primary, 1 | 1.64e-03 | 7 | 265 | 2 | C4552070 | |
| Disease | Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia | 1.64e-03 | 7 | 265 | 2 | C3714844 | |
| Disease | Polyomavirus Infections | 1.64e-03 | 7 | 265 | 2 | C0949804 | |
| Disease | PULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED | 1.64e-03 | 7 | 265 | 2 | C1969342 | |
| Disease | Pulmonary Hypertension, Primary, Fenfluramine-Associated | 1.64e-03 | 7 | 265 | 2 | C1969343 | |
| Disease | HMG CoA reductase inhibitor use measurement | 1.66e-03 | 189 | 265 | 7 | EFO_0009932 | |
| Disease | Alzheimer's disease (biomarker_via_orthology) | 1.84e-03 | 58 | 265 | 4 | DOID:10652 (biomarker_via_orthology) | |
| Disease | Amyotrophic Lateral Sclerosis | 1.84e-03 | 58 | 265 | 4 | C0002736 | |
| Disease | Alzheimer disease, APOE carrier status | 1.94e-03 | 98 | 265 | 5 | EFO_0007659, MONDO_0004975 | |
| Disease | smoking status measurement | CAAP1 KIF26A NCAM1 TMEM132B DCAF5 RYR2 KIF2B INSC MED12L DNAH8 SDK1 SMG6 TCF20 ZNF521 LINGO2 NLGN1 REV3L FBXL16 CPEB4 ROBO2 CTNNA2 | 1.95e-03 | 1160 | 265 | 21 | EFO_0006527 |
| Disease | stroke | 1.97e-03 | 144 | 265 | 6 | EFO_0000712 | |
| Disease | glaucoma (biomarker_via_orthology) | 1.99e-03 | 28 | 265 | 3 | DOID:1686 (biomarker_via_orthology) | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 2.04e-03 | 145 | 265 | 6 | DOID:1289 (implicated_via_orthology) | |
| Disease | pain | 2.05e-03 | 196 | 265 | 7 | EFO_0003843 | |
| Disease | non-high density lipoprotein cholesterol measurement | GGNBP2 TRPS1 BBS1 ZNF235 BMPR2 ALDH1A2 CARMIL1 AKNA KANK2 CCND2 ZZZ3 UNC5CL ITSN2 MYLIP RP1 | 2.14e-03 | 713 | 265 | 15 | EFO_0005689 |
| Disease | benign neoplasm (implicated_via_orthology) | 2.17e-03 | 8 | 265 | 2 | DOID:0060072 (implicated_via_orthology) | |
| Disease | pappalysinâ1 measurement | 2.20e-03 | 29 | 265 | 3 | EFO_0010618 | |
| Disease | smoking status measurement, Cannabis use, schizophrenia | 2.20e-03 | 29 | 265 | 3 | EFO_0006527, EFO_0007585, MONDO_0005090 | |
| Disease | Headache | 2.65e-03 | 64 | 265 | 4 | HP_0002315 | |
| Disease | presubiculum volume | 2.67e-03 | 31 | 265 | 3 | EFO_0009400 | |
| Disease | QRS-T angle | 2.73e-03 | 106 | 265 | 5 | EFO_0020097 | |
| Disease | Gout | 2.77e-03 | 9 | 265 | 2 | C0018099 | |
| Disease | microcephaly (implicated_via_orthology) | 2.93e-03 | 32 | 265 | 3 | DOID:10907 (implicated_via_orthology) | |
| Disease | C-reactive protein measurement | DCHS2 TRPS1 SSPOP BHMT BMPR2 ALDH1A2 PXDN KLHL7 UVRAG BANK1 USP47 CARMIL1 ZNF316 GATC MIB2 LINGO2 NLGN1 SIX3 KANK2 MACF1 SCAF11 | 3.09e-03 | 1206 | 265 | 21 | EFO_0004458 |
| Disease | aortic aneurysm | 3.45e-03 | 10 | 265 | 2 | EFO_0001666 | |
| Disease | Fanconi anemia (is_implicated_in) | 3.45e-03 | 10 | 265 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | cardiac troponin T measurement | 3.79e-03 | 219 | 265 | 7 | EFO_0005043 | |
| Disease | glomerular filtration rate, renal transplant outcome measurement | 3.79e-03 | 35 | 265 | 3 | EFO_0005199, EFO_0005208 | |
| Disease | FEV/FEC ratio | ARHGAP42 DCHS2 HDAC4 SPEG TRPS1 DGKB DGKG NCAM1 CEMIP2 TTC7B KLHL7 RIPOR1 PCDH10 SMG6 ENOX1 DSPP DENND3 FAF1 CPEB4 LRP1 SPATA13 | 3.80e-03 | 1228 | 265 | 21 | EFO_0004713 |
| Disease | cardiomyopathy (implicated_via_orthology) | 3.86e-03 | 71 | 265 | 4 | DOID:0050700 (implicated_via_orthology) | |
| Disease | response to bronchodilator, FEV/FEC ratio | DLGAP2 MYO7A CCDC178 ITGA4 TMEM132B FANCD2 FAT2 ALDH1A2 THSD7A KALRN LINGO2 DENND3 RLF UNC5CL ROBO2 | 4.17e-03 | 766 | 265 | 15 | EFO_0004713, GO_0097366 |
| Disease | granulosa cell tumor (is_marker_for) | 4.19e-03 | 11 | 265 | 2 | DOID:2999 (is_marker_for) | |
| Disease | diffuse scleroderma (is_implicated_in) | 4.19e-03 | 11 | 265 | 2 | DOID:1580 (is_implicated_in) | |
| Disease | kidney cancer (implicated_via_orthology) | 4.19e-03 | 11 | 265 | 2 | DOID:263 (implicated_via_orthology) | |
| Disease | leucine measurement | 4.26e-03 | 73 | 265 | 4 | EFO_0009770 | |
| Disease | alcohol consumption measurement | DLGAP2 KIF26A KDM4C TRPS1 BBS1 NCAM1 ITGA4 SDK1 BANK1 THSD7A NTRK2 ZNF521 ENTHD1 LINGO2 SIX3 FAF1 NBAS ZZZ3 CDK5RAP2 SCAF11 CTNNA2 | 4.32e-03 | 1242 | 265 | 21 | EFO_0007878 |
| Disease | phosphatidylcholine measurement | 4.34e-03 | 284 | 265 | 8 | EFO_0010226 | |
| Disease | vitamin D deficiency | 4.44e-03 | 37 | 265 | 3 | EFO_0003762 | |
| Disease | Colorectal Carcinoma | OBSCN FAT1 DNAH8 KALRN SYNE1 IFNA2 CCND2 CD93 MSH6 ZZZ3 GUCY1A2 ICAM5 LRP1 VRTN | 4.75e-03 | 702 | 265 | 14 | C0009402 |
| Disease | nicotine dependence (implicated_via_orthology) | 5.00e-03 | 12 | 265 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth Disease | 5.00e-03 | 12 | 265 | 2 | C0007959 | |
| Disease | Mental Disorders, Severe | 5.00e-03 | 12 | 265 | 2 | C4046029 | |
| Disease | Diagnosis, Psychiatric | 5.00e-03 | 12 | 265 | 2 | C0376338 | |
| Disease | level of Phosphatidylcholine (14:0_18:1) in blood serum | 5.00e-03 | 12 | 265 | 2 | OBA_2045062 | |
| Disease | Behavior Disorders | 5.00e-03 | 12 | 265 | 2 | C0004930 | |
| Disease | Mental disorders | 5.00e-03 | 12 | 265 | 2 | C0004936 | |
| Disease | anti-Epstein Barr virus antibody measurement | 5.00e-03 | 12 | 265 | 2 | EFO_0009273 | |
| Disease | extrapulmonary tuberculosis | 5.00e-03 | 12 | 265 | 2 | MONDO_0000368 | |
| Disease | Alzheimer disease, dementia | 5.00e-03 | 12 | 265 | 2 | MONDO_0001627, MONDO_0004975 | |
| Disease | autosomal dominant compelling helio-ophthalmic outburst syndrome | 5.15e-03 | 77 | 265 | 4 | EFO_0007887 | |
| Disease | skin microbiome measurement | 5.16e-03 | 39 | 265 | 3 | EFO_0801228 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EAVATGLQDFIICIE | 286 | Q9NVA4 | |
| GESLCQNSIEELDGV | 296 | Q8NDB2 | |
| CLEVDVNDIDVVGQD | 1001 | Q13075 | |
| GEINELKQVEGEASC | 56 | Q719I0 | |
| EAACDIARQVADEGD | 101 | Q93088 | |
| DEIVNDRDCSAVENG | 76 | Q86US8 | |
| NNAEGSCIEERNVDL | 581 | A6H8Y1 | |
| LSQCSAGELEIVVEA | 2291 | Q96N23 | |
| CVQDEEANTDDLTTL | 176 | Q9BXY5 | |
| EQAGEVLESAVLALC | 616 | O15254 | |
| CLQAQAEDVAAAVEA | 71 | Q8IZ83 | |
| GEAVSEALCVVLNNV | 796 | O94812 | |
| AVQVQNEEGKCEVTE | 46 | O95433 | |
| ATGEQVCEVQEADKA | 61 | O94788 | |
| LQCGETDLDLTVQET | 1016 | P41180 | |
| VEAQVTGVLDDCLCD | 31 | Q86YB8 | |
| TNCTEELENAGVEVL | 276 | P00390 | |
| GEVDAEELQRCLTQS | 66 | P28676 | |
| VLAGEDGTQCQDVDE | 416 | Q9NPY3 | |
| AINELISDGSVVCAE | 186 | Q9NR80 | |
| QQNVDVFAADICGVT | 226 | Q9BXX3 | |
| QDVVVNELIDCGAIV | 251 | O15084 | |
| HEEAVGQVCVSELEQ | 1521 | Q8IYW2 | |
| ITEDELTAQDITECN | 61 | Q9ULD4 | |
| CVSQVSEAEINGQFE | 526 | Q9P1A6 | |
| VVEAAVQECSQSVDE | 66 | P56282 | |
| EDEIIENSCRNEGNT | 196 | Q9NZW4 | |
| CTGTEDTLAQCEQEE | 96 | O43866 | |
| VDSVDEGCNITEGEQ | 191 | Q9ULJ7 | |
| GSDLVSQQDICIDSA | 216 | Q9H8G2 | |
| DLDTCEVTVEGEELN | 716 | O94985 | |
| DGINIDIEQEVNCLS | 136 | Q01459 | |
| CSSVTDLIVQDGQEA | 986 | A2RUS2 | |
| ALAVEDLGCGVIQVD | 1756 | Q9UKL3 | |
| LLEDTVGEVVDVNEC | 1006 | Q5T5Y3 | |
| VGEVVDVNECDLSIE | 1011 | Q5T5Y3 | |
| AIQAGCSQEEDSVSL | 516 | Q9Y2H0 | |
| SCAVGLAVLDIIENE | 316 | Q8TBG4 | |
| SVACVQLDQGQDVEV | 1036 | Q76LX8 | |
| QLDQGQDVEVDEAAC | 1041 | Q76LX8 | |
| EAIITVLCGTEGAQD | 1141 | Q96SN8 | |
| RQGDTVDVLCEVDQA | 421 | Q86UR1 | |
| EQLAGVSAEQEVTCI | 241 | Q6PCD5 | |
| ALERAEELCSQVNEG | 1381 | Q9NZM3 | |
| IAQCTVEVEVIDEND | 326 | Q9UN71 | |
| SVGAAICGLQQDEEV | 206 | P30279 | |
| SDSQEVQCLELESVD | 816 | Q8N7Z5 | |
| VQCLELESVDQTEAV | 821 | Q8N7Z5 | |
| QDVRAEEGQDVCLEV | 1456 | O75147 | |
| EEGQDVCLEVETGRV | 1461 | O75147 | |
| SEAEEVCNLSGADAV | 266 | Q8IYW4 | |
| VTVDDCDQGANGDIA | 276 | Q14517 | |
| CDDTAAAVVDETGNV | 46 | Q9H4B0 | |
| CGTEVALDLLEEQAI | 406 | Q96F46 | |
| LNDLEACVIQEVGVE | 116 | P01566 | |
| SLIEAQTCENEEAET | 1041 | P56524 | |
| QAEIEAERCGESEVL | 536 | Q86YW9 | |
| SDNVVEGNCADELLQ | 91 | O43716 | |
| QQSLELDDQDTCGID | 11 | O60551 | |
| TDEAVECTEDELNNL | 311 | Q9UDY8 | |
| TEDGNTCVEVIVTNE | 421 | Q9H3C7 | |
| DVDLQSVDINQCASG | 271 | Q6PRD1 | |
| LAELAAQGVTEDCLE | 606 | Q86UW9 | |
| TVVDDADTVELCGAL | 191 | Q8N335 | |
| DIITDEELCQIQESG | 1281 | Q9BQS8 | |
| VSVVQDGVATLECNA | 2276 | Q8NDA2 | |
| SEEAEEGDELQQRCL | 181 | Q96ED9 | |
| EDQVLDADGVTCLAN | 831 | Q07954 | |
| DASQAEVCAGTVAEV | 516 | Q2KJY2 | |
| INSDEIQICGAEIFV | 106 | Q99665 | |
| LNDLEACVIQEVGVE | 116 | P01568 | |
| ASATGNVCIEEIDVD | 436 | P20700 | |
| VIITVDDSDDNNDCS | 11 | Q8NDZ0 | |
| ATSVADEGIDIAQCN | 696 | O95786 | |
| VNEELEEALEACENA | 301 | Q5BJE1 | |
| IQSRAVSCVEEDIQG | 396 | Q8N6G6 | |
| SDGELSVCGQQVEVD | 41 | Q5SYE7 | |
| CEESGLERGEEQEQS | 1161 | Q9UKJ3 | |
| CEIQAALEEAEASLE | 1541 | P13535 | |
| CQQREVEAITEGVEE | 1621 | Q96RV3 | |
| CKAELEAQVGVEQAA | 521 | Q9H6A9 | |
| CAGNEDIITLRAEDN | 81 | P12004 | |
| GCLDAVVVNEEALDL | 3911 | Q9NYQ8 | |
| NVQEAESSGEAVCLN | 871 | Q9UMF0 | |
| DRDEGENAAVTCVVA | 421 | Q08174 | |
| TCELALEGLTDNEVE | 241 | P14222 | |
| DNEVEDCLTVEAQVN | 251 | P14222 | |
| DVAEGSTLEEVSNNC | 206 | O76074 | |
| LEAAQDLIQCAVVEG | 291 | Q96LB9 | |
| AVEENIGSDAASCIL | 2716 | Q96JB1 | |
| LNDLEACVIQEVGVE | 116 | P01567 | |
| EDVCADSVDAVQELI | 666 | O60229 | |
| ALSNESDSEENVCEV | 526 | Q96JK2 | |
| LNVEEGCSADEVRES | 56 | Q9NX36 | |
| EVAGTAQCEGLETQE | 621 | Q8N3D4 | |
| AQCEGLETQETEVGV | 626 | Q8N3D4 | |
| NTVLDVVEEECGISI | 156 | Q9H3R0 | |
| QANTAVVEDGSDCLA | 366 | O94854 | |
| EVEAKANGEDCLNQV | 16 | Q8WY64 | |
| SQVGTQECAIVEFEE | 251 | Q9BRS8 | |
| QECAIVEFEEVEAAI | 256 | Q9BRS8 | |
| LVFDTEVDVVGLCQE | 81 | P50748 | |
| EQAEVCSGTVADVLQ | 441 | Q9ULI4 | |
| LVDEGQTVQLECSAD | 421 | Q7L985 | |
| IVGVQDLLDQESVCV | 71 | O95163 | |
| ICVVDTCGANEETLE | 571 | Q8IXQ5 | |
| ECSSLQEAVQAAEAG | 201 | Q15274 | |
| EETVCKAIEAVAAQG | 236 | Q8N0Y7 | |
| GCNVSDTVELVECLQ | 361 | Q8N2Q7 | |
| DSEENGQVQCELLGD | 386 | Q9P2E7 | |
| NDILIGCEEEEQENG | 1111 | P52701 | |
| EEQCSVALGEGQEVA | 286 | Q68DD2 | |
| NGKDVEEVSCIETQD | 811 | Q9H422 | |
| QEELDLIQAVGCLEE | 1211 | A2RRP1 | |
| EDADEIIQCDNCGIT | 331 | O94880 | |
| CLQVAQDCGTDVLDL | 166 | Q2TAA2 | |
| QDGRLEVCIQDTDGT | 186 | Q6ZV29 | |
| GECESLTELVLTENQ | 286 | Q9BTT6 | |
| RCGALENLVNDVSDE | 431 | Q9BTT6 | |
| LEELVSAAGQDCAEV | 266 | D6RGH6 | |
| AEQVLLEQLDEDGGC | 241 | Q8N8X9 | |
| ESVAQCLSCIQGEVD | 71 | Q9NYR8 | |
| ENNVGLITLDNDCEV | 531 | A2A3N6 | |
| TCLVSITVDDVNDNE | 646 | Q6V1P9 | |
| DTEAQVGDALRLECV | 4906 | Q5VST9 | |
| FVAQDTLECQVAEVE | 211 | Q9Y3R4 | |
| VIQAEGEEVKASACQ | 56 | Q9Y2Y8 | |
| QTLDLEDCGIVDSQL | 351 | O95522 | |
| VSACQLEKEEENEGE | 21 | C9JE40 | |
| DCEGIVVFQGVECEE | 626 | Q52LW3 | |
| TVSSEENVCDIGNEE | 2641 | Q8NFC6 | |
| IELECDGVGVDLSNI | 636 | P49619 | |
| LCAEEAAAQEQTGQV | 1016 | Q92896 | |
| AAAQEQTGQVEECLK | 1021 | Q92896 | |
| LDLDEIENDNGTVRC | 1486 | Q14008 | |
| TDGRDQTIALEECNQ | 1296 | Q8N6C5 | |
| VTLDLDCVQDVLGAA | 126 | Q53HC5 | |
| AVNNDICLDEVAEEL | 136 | A0AVK6 | |
| SSVQALIDACIEEDG | 386 | Q7Z5Q1 | |
| QGVSDQAVAEALCSI | 201 | Q8WTW3 | |
| VNKCVIALQEGDVDT | 521 | P26232 | |
| NLEGAVSANQCSVDE | 1511 | P49454 | |
| CEGDVANEVETEQIL | 291 | Q92562 | |
| ANEVETEQILCDASV | 296 | Q92562 | |
| GDCSVEVRQEDQQLD | 551 | Q8NHY3 | |
| LSEQLDTCEESVDQV | 41 | P0CW27 | |
| AEDLVANGALVSICN | 116 | Q13418 | |
| QTQLAEQGEESRECL | 126 | Q9NWU2 | |
| EVLEGAVNLRDCESA | 386 | Q13873 | |
| EGQDSGDICSEENQI | 126 | Q9Y2G2 | |
| VREQAVEGGEVELSC | 131 | Q8NFZ8 | |
| EIECDGVQIDLINIS | 641 | Q9Y6T7 | |
| AGRDQAICELQEEVS | 1071 | Q7Z591 | |
| NIVIQGEVEDSCYAE | 491 | Q9UHN6 | |
| EENCSVIQTSCQEGD | 411 | Q9Y5Q5 | |
| AQGCEDIIAESISLD | 386 | Q9P203 | |
| GCIEEQGVEDSANED | 6 | P55210 | |
| VFIEEDCVVNAAQIG | 91 | Q9BTE1 | |
| NDLEACVIQGVGVTE | 116 | P01563 | |
| CQSQDGAEAALQEIE | 486 | O15068 | |
| INCEVTDNSGVVQLD | 696 | P13612 | |
| EVEATRGQVCQEQEL | 521 | Q6ZW76 | |
| SVLEQCASDIIQENG | 446 | Q1MX18 | |
| DVRQDLADVVQVCEG | 4426 | Q14204 | |
| CEADVNVQDDDGSTA | 761 | Q63ZY3 | |
| SEVEENGAVEIARCS | 331 | P31323 | |
| AAVCAANIVSQDGEQ | 1001 | Q5VZK9 | |
| SSVQALIDACIEEDG | 526 | Q17RY0 | |
| LCEEIAGEIESDNVE | 306 | Q5FWF5 | |
| LCNEGQIASDEEELV | 341 | Q96QF7 | |
| NVDVVLEDTCTVGEI | 111 | Q9UNN5 | |
| ADEDAVSCLVLGTEN | 211 | Q8NFJ9 | |
| QDGVVTIEEFLEACQ | 226 | Q9Y2W7 | |
| QELIECVANSDEQLG | 251 | Q96RP9 | |
| EEVICQSETIAEGQT | 376 | Q92681 | |
| ENTGIEANVLCLESE | 496 | Q99590 | |
| ISAEVEETVDIGCQA | 396 | Q7Z5N4 | |
| VFCNGESVEENANVV | 2306 | Q92736 | |
| QIALNVDGACADETS | 76 | Q9NVU0 | |
| EIIQEVFEQCGDITA | 156 | Q8TC92 | |
| LNDAQVVEAVCAIFE | 696 | O94829 | |
| VNVLNICSDDELGSE | 366 | Q08209 | |
| EACQDVARIEGIAED | 406 | Q6PJW8 | |
| CVEEVLNLVEIGNSC | 396 | Q8N4N8 | |
| ICSGNEAEVDTALDV | 481 | Q9BXW9 | |
| IAAEGDQEVLDSVCQ | 506 | Q99549 | |
| DVLQTNIEECLGAVE | 111 | Q96DY7 | |
| LLVDAGCSVNAEDEE | 686 | Q96AX9 | |
| SNNSIVEEDVVDCVV | 571 | P56715 | |
| EEIEDVSGILQCTAN | 146 | P33402 | |
| QEGVILDDVDSSVCR | 171 | Q9BV86 | |
| LGQETVVCSAQVVDA | 221 | Q9BQI9 | |
| DCINVADDAIAAISQ | 251 | Q8N461 | |
| AVTLGGSLDENCQEV | 786 | Q9Y4G2 | |
| ETKETAVQCDVGDLQ | 336 | Q8N1G1 | |
| CCTVEQAEEIIGLEA | 626 | Q9P2Y5 | |
| GEEVNSCVEVLLEEA | 176 | P49589 | |
| CLEVEVQTAGEQVAD | 1546 | O60522 | |
| CSDLQEGIVCQDDQV | 4081 | A2VEC9 | |
| ATEIQDVCSAVGLNV | 46 | P09132 | |
| TQVQEVVCINSDGEE | 596 | Q9UPZ6 | |
| VVCINSDGEEVDRQL | 601 | Q9UPZ6 | |
| ENGDNRDVIEDTLGC | 6446 | Q8NF91 | |
| QEDGSVVDVSESVEC | 451 | Q14DG7 | |
| GEEAQEALQDLENTC | 271 | Q8WUG5 | |
| DDQIAQSLCGEDLII | 236 | Q13148 | |
| CIGDAETDDEISIAQ | 71 | A6NI28 | |
| QDAITCVSESGEDII | 171 | Q8IZX4 | |
| LNDLEACVTQEVGVE | 116 | P05015 | |
| LDDCGIVDSQVNAIL | 356 | Q5VT98 | |
| QVASVCETLEETGDI | 91 | O95343 | |
| SCVIVDEAGQSCEIE | 2176 | Q7Z333 | |
| GQAEEVVQERICDDE | 346 | P17987 | |
| DEATSALDVQCEQAL | 631 | Q03519 | |
| GDIIQNSEDGVECKI | 76 | Q13017 | |
| LGDCDTLQVDEAQVQ | 926 | Q01974 | |
| VTEAIGDCENLSELI | 281 | Q14160 | |
| EQVEGNCEIVNELIA | 606 | Q8NEM2 | |
| LNDLEACVIQEVGVE | 116 | P05014 | |
| SNQETCVEIDESVRG | 36 | P21108 | |
| QCEDLADDTVLVGGE | 1166 | Q66K14 | |
| ECNGGVAEEDEVEVI | 266 | Q9NRA8 | |
| CESLSVQGEEDLSVE | 646 | Q6ZVT6 | |
| EEIQNESACGLDVGE | 516 | Q9ULV3 | |
| EGEDAVIVCDVVSSL | 131 | P13591 | |
| ICIAENKAGEQDATI | 286 | P13591 | |
| CVAENLVGEDQDSVN | 266 | Q16620 | |
| NVIFLEVDVDDCQDV | 51 | P10599 | |
| NELISDGNVVCAEAL | 141 | Q96N96 | |
| DNTIGIEENAVSLTC | 2006 | O75443 | |
| DLDDCGIIDSQVNAI | 356 | Q5VXH4 | |
| GIDVDAENCAVCIEN | 261 | Q8NC42 | |
| CQEQDITTANGEEDG | 716 | Q9UHF7 | |
| NANGDVVEEEENSCT | 151 | Q96E35 | |
| ALCGIAEATQIDNVA | 811 | Q9C0E2 | |
| CGRDQEDVVSQTESL | 3581 | Q96T58 | |
| VEEVSTGQECGVVLD | 516 | P49588 | |
| QSTCELEVDAVAADI | 231 | O60673 | |
| DIICNLESEGQDNTA | 281 | Q13129 | |
| EENECSLVVLSTGAQ | 1536 | Q15772 | |
| EVVEQSLGTCNLATE | 516 | Q0IIM8 | |
| KINQCQLTDGVDVED | 66 | Q96K83 | |
| DSSEGNVAVECDQVT | 21 | Q5SVQ8 | |
| DVLVCQRLSDQAGED | 391 | Q5TEJ8 | |
| CLSINQEETSEEAEI | 211 | Q8TEQ6 | |
| DLDDCGIIDSQVNAI | 356 | Q5TYX0 | |
| DRVVIEGQTVDFQCE | 441 | Q92626 | |
| EFNGDGAVEVCQLIV | 301 | O75695 | |
| DIQCVEEFGANATVE | 146 | O14798 | |
| NDDGVDEGICLETNS | 456 | Q96K76 | |
| ADENEDCSALTNEII | 351 | Q8IV45 | |
| QAVSESDDIVCGISD | 1891 | Q9HCK1 | |
| SQNICCQEIVNGEEV | 1636 | Q8IWV7 | |
| DQCQGLREETEATQV | 31 | Q9UJ04 | |
| TLGNQQDIIDTACEV | 396 | Q5SRE5 | |
| CTEEGQLENQVIAFE | 456 | Q96L92 | |
| VLEEEAVEFRCQVQG | 236 | Q9HCK4 | |
| CAVCGQQIFVDVSEE | 226 | Q9H920 | |
| SNLGVEDVNLLCGEE | 516 | Q9NW08 | |
| GQQLVEAAEIDCQDL | 1541 | P11277 | |
| RQGIEDAEETANQTC | 236 | A6NIE6 | |
| LSEQVEDCVLTVEGS | 646 | O43548 | |
| CELGAVCTIINAEEE | 1641 | Q9UGU0 | |
| ICQADIVEAVDIASA | 171 | O15213 | |
| TAGCQELVTFEDVAV | 151 | A6NFI3 | |
| EVLQAQGNDAAATEC | 806 | Q86TV6 | |
| LVADCASEAVIDANG | 181 | P17010 | |
| VECNVLELDQVDDGA | 91 | Q86VQ6 | |
| ALSCQEVTDDEVLDA | 126 | Q70CQ3 | |
| NQISQCESEDLGITE | 1436 | Q5VWN6 | |
| QSLQQGTCLETEDVA | 181 | O15482 | |
| CRNTEEVEAILNGDV | 336 | Q9Y210 | |
| IDAEGECQEGEILAT | 41 | Q6PF06 | |
| VLQELQEAVECEGLE | 11 | Q9H8Y1 | |
| QLEDEDVQTRVAGCL | 1141 | Q6ZS17 | |
| AVNGVDDSDSAVINC | 201 | Q8IYH5 | |
| GESIQASVDDNCLVN | 146 | Q14590 | |
| CAQAGADVVDVAADS | 786 | P11498 | |
| VEVEEGEVNGQELCI | 506 | Q8WY91 | |
| CASEQEEEQLVAVEA | 446 | Q9H3U1 | |
| IGSADCNVIEIDDTL | 256 | Q6PEW1 | |
| EQAARVGTQVEEAAE | 246 | Q9BRZ2 | |
| CRDTEEVEAILNGDV | 281 | Q9HCX4 | |
| GQDDLTVVLNEEGIC | 221 | Q96JC1 | |
| EAAVCDISNDAVNIS | 146 | Q8N402 | |
| AQQTGAECEETEVDQ | 531 | Q9BYP7 | |
| DELEEETGNVQAQGC | 146 | Q86W25 | |
| VCEAVRSGNEEVLAD | 376 | Q6IA69 | |
| CDSGQVQVVDDEDNE | 31 | Q13402 | |
| VITNGGQCEAELIVE | 421 | Q14324 |